BCR and chronic myelogenous leukemia, BCR-ABL1 positive: BCR–ABL expression promotes CML due to damaged cell adhesion capacity cells (Overduin et al., 1992; Musacchio et al., 1994; Willis et al., 2005; Vaidya et al., 2015), causing uncontrolled blood cells’ growth in CML patients.